Both in Pharmaceuticals
Cronos Group Inc. Common Share vs AnaptysBio
Over the past year CRON returned +51.8% and ANAB returned +26.6%; their daily moves had a correlation of 0.04.
CRON +51.8% ANAB +26.6%Growth of $1, one year, split-adjusted
| Metric | CRON | ANAB |
|---|---|---|
| Price | $3.72 | $45.58 |
| Market cap | $1.37B | $1.36B |
| Today | +5.98% | −4.06% |
| 1 month | +14.8% | −0.2% |
| 6 months | +44.7% | −31.9% |
| Year to date | +41.4% | −6.0% |
| 1 year | +51.8% | +31.2% |
| Revenue growth (YoY) | +59.5% | −8.0% |
| Gross margin | 65.8% | 100.0% |
| Net margin | 45.4% | −206.9% |
| P/E (TTM) | 19.6× | — |
| Price / sales | 5.3× | 5.9× |
| Net cash | $797.0M | $286.5M |
| Dividend yield | — | — |
| Volatility (60d) | 31.4% | 40.6% |
| Short % of float | 2.1% | 30.6% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).